About Us
Dr. Suchismita Acharya started AyuVis because of her passion to find a solution to the problem of antibiotic resistance to drugs and to target the unmet clinical needs in life-threatening indications.
The company’s lead program started in the antibiotic/immunomodulatory space to treat bacterial induced hospital-based complicated Intra-Abdominal Infections (cIAI), a critical infectious disease which exhibits high rates of bacterial resistance and high patient morbidity and death. The company since then has expanded its research significantly towards Bronchopulmonary Dysplasia (BPD).